|
 |
Pharmaceutical Manufacturing and Packing Sourcer
|
A Look at Pharmaceutical Manufacturing and Packing Processes
Waste and How it Damages your Company
When you read the word 'waste', what do you think this means to you and the business you work for or maybe own? Have you considered all the forms of waste that can effect the quality, delivery schedule and cost of your products, and ultimately your bottom line? In today's increasingly competitive climate, can you afford not to make the maximum effort to eradicate waste from your company? Moreover, given the increased pressure on your company's margins, can you eliminate waste without having to resort to the risks associated with increasing expenditure on new capital equipment which makes heady promises to increase machine throughput by x% and machine capacity by y%?
This is a conundrum facing many manufacturers; and all of these manufacturers, encompassing all sectors, from packaging manufacture to food processing to process industries, can look towards lean manufacturing principles and philosophy as a means by which they can gain that competitive edge and ensure sustainable growth in the future. |
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
4th Annual Patient Recruitment and Retention in Clinical Trials
13-15 October 2008, Amsterdam
Patient recruitment
is now consuming thirty percent of clinical trial time - more time than any
other clinical trial activity - and almost half of all trial delays result from
patient recruitment problems.
As the
recruiting culture becomes more sophisticated and the forces affecting patient
enrollment grow more numerous and complex, pharmaceutical companies are
striving to discover new strategies to facilitate enrollment in clinical
trials.
With
increasing industry pressure to develop, test and market greater numbers of new
drugs faster, pharmaceutical companies need to perform clinical trials as
quickly as possible. Inefficient patient recruitment processes is a formidable
barrier to pharmaceutical companies' success in launching new products.
Improving the patient recruitment process is imperative to avoid wasted
investments and eliminate costly delays in bringing new drugs to market --
today and even more so in the not-so-distant future. Improved patient
recruitment presents one of the largest opportunities for pharmaceutical
companies to eliminate delays in clinical trials, thereby making it possible to
reduce time to market. With patent time limits and large overheads
meaning that any delays in the development timeline can be disastrous, a good
understanding of how to successfully recruit patients for trials is vital for
any company looking to succeed.
More info >> |
|
 |
News and Press Releases |
 |
Azopharma Announces Plans to Implement XcelodoseTM Technology in the Production of Early Stage Clinical Trial Materials
HOLLYWOOD, Fla. – Azopharma Product Development Group, Inc. (“Azopharma”) announced today plans to implement Xcelodose technology at its formulations development facility, ApiCross Drug Delivery Technologies. Xcelodose technology is a powder micro-dosing system developed by Meridica. This technology offers a unique powder dispensing system for small-scale capsule filling and ultimately assists in conserving valuable research material as well as reducing various Preformulation activities.
More info >> |
|
 |
